KPV— 5mg

KPV — 5 mg

KPV is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte–stimulating hormone (α-MSH), widely studied in research settings for its selective interaction with inflammatory and immune-related signaling pathways. Researchers examine it for how it influences cytokine signaling, epithelial barrier integrity, and downstream cellular response markers without broadly activating endocrine hormone systems.

Key Research Observations on KPV

Selective modulation of inflammatory signaling
Research literature describes KPV as a peptide investigated for its interaction with pathways involved in inflammatory cytokine regulation, particularly those associated with localized immune responses.

Interest in epithelial and barrier function pathways
Studies explore how KPV may influence signaling related to epithelial tissue integrity, making it a subject of interest in gastrointestinal and mucosal research models.

Minimal interaction with melanocortin endocrine effects
Scientific investigations note that KPV retains anti-inflammatory signaling properties of α-MSH–derived sequences without activating broader melanocortin or endocrine pathways.

Exploration of immune and stress-response modulation
Academic and preclinical research examines KPV for its downstream effects on immune balance markers, cellular stress responses, and tissue-level signaling regulation in controlled research settings.